LIVE·NEON · 1,211 CONTRACTS
ContractLocal CCP

H2593·Elevance Health, Inc.

HMO/HMOPOS · observed 2026 → 2026 · 75 months of CPSC history · 16 active CY 2026 plans.

Latest enrollment
11.3K
2026-05
93.1K vs 2020-11 peak
Months of data
75
History range
2020-01 → 2026-05
CY 2026 plans
16
01 · Trend

Monthly enrollment

fact_enrollment_cpsc · 75 months
104,4154,700
02 · Plans

CY 2026 plan roster

fact_landscape ⋈ fact_enrollment_cpsc · 16 plans
PlanCategoryPremiumMOOPCountiesEnrollment
Wellpoint Full Dual Advantage Aligned (HMO D-SNP)
H2593/046 · Dual-Eligible
SNP$0$9,2503.5932,627
Wellpoint Full Dual Advantage Aligned (HMO D-SNP)
H2593/044 · Dual-Eligible
SNP$0$9,2503.5111,603
Wellpoint Medicare Advantage 2 (HMO-POS)
H2593/029
MA-PD$0$9,2503.5831,515
Wellpoint Full Dual Advantage 2 (HMO D-SNP)
H2593/051 · Dual-Eligible
SNP$5$9,2503.581,505
Wellpoint Full Dual Advantage Aligned (HMO D-SNP)
H2593/047 · Dual-Eligible
SNP$0$9,2503.5151,173
Wellpoint Dual Advantage 2 (HMO D-SNP)
H2593/032 · Dual-Eligible
SNP$0$9,2503.5841,111
Wellpoint Full Dual Advantage Aligned (HMO D-SNP)
H2593/045 · Dual-Eligible
SNP$0$9,2503.514608
Wellpoint Full Dual Advantage (HMO D-SNP)
H2593/053 · Dual-Eligible
SNP$0$9,2503.52501
Wellpoint Kidney Care (HMO-POS C-SNP)
H2593/043 · Chronic or Disabling Condition
SNP$0$2,9003.556453
Wellpoint Kidney Care (HMO-POS C-SNP)
H2593/031 · Chronic or Disabling Condition
SNP$0$9,2503.56117
Wellpoint Full Dual Advantage 2 (HMO D-SNP)
H2593/048 · Dual-Eligible
SNP$5$9,2503.5998
Wellpoint Medicare Advantage 2 (HMO-POS)
H2593/001
MA-PD$0$8,3003.510
Wellpoint I CareMore Home Care 2 (HMO I-SNP)
H2593/003 · Institutional
SNP$0$1,5003.520
Wellpoint Lung Care 2 (HMO-POS C-SNP)
H2593/005 · Chronic or Disabling Condition
SNP$0$8,3003.510
Wellpoint Chronic Care 2 (HMO-POS C-SNP)
H2593/006 · Chronic or Disabling Condition
SNP$0$8,3003.510
Wellpoint I CareMore Kidney Care (HMO-POS C-SNP)
H2593/040 · Chronic or Disabling Condition
SNP$0$3,0003.510
03 · Quality

Star Ratings · contract-level

fact_star_ratings · 2 years
Star scale · 1.0 – 5.0★ summary
1.02.03.04.05.0202520263.53.53.03.03.53.5
  • Overall
    3.53.5
    0.020252026
  • Part C
    3.03.0
    0.020252026
  • Part D
    3.53.5
    0.020252026
Measure breakdown · CY 2026 · 45 measures
IDMeasure
C01Breast Cancer Screening2.0
C02Colorectal Cancer Screening2.0
C03Annual Flu Vaccine3.0
C04Improving or Maintaining Physical Health
C05Improving or Maintaining Mental Health
C06Monitoring Physical Activity4.0
C07Special Needs Plan (SNP) Care Management1.0
C08Care for Older Adults – Medication Review4.0
C09Care for Older Adults – Pain Assessment3.0
C10Osteoporosis Management in Women who had a Fracture
C11Diabetes Care – Eye Exam2.0
C12Diabetes Care – Blood Sugar Controlled3.0
C13Kidney Health Evaluation for Patients with Diabetes3.0
C14Controlling High Blood Pressure2.0
C15Reducing the Risk of Falling
C16Improving Bladder Control
C17Medication Reconciliation Post-Discharge3.0
C18Plan All-Cause Readmissions3.0
C19Statin Therapy for Patients with Cardiovascular Disease3.0
C20Transitions of Care2.0
C21Follow-up after Emergency Department Visit for People with Multiple High-Risk Chronic Conditions2.0
C22Getting Needed Care
C23Getting Appointments and Care Quickly
C24Customer Service
C25Rating of Health Care Quality
C26Rating of Health Plan2.0
C27Care Coordination
C28Complaints about the Health Plan4.0
C29Members Choosing to Leave the Plan3.0
C30Health Plan Quality Improvement5.0
C31Plan Makes Timely Decisions about Appeals
C32Reviewing Appeals Decisions
C33Call Center – Foreign Language Interpreter and TTY Availability5.0
D01Call Center – Foreign Language Interpreter and TTY Availability5.0
D02Complaints about the Drug Plan4.0
D03Members Choosing to Leave the Plan3.0
D04Drug Plan Quality Improvement5.0
D05Rating of Drug Plan3.0
D06Getting Needed Prescription Drugs
D07MPF Price Accuracy5.0
D08Medication Adherence for Diabetes Medications2.0
D09Medication Adherence for Hypertension (RAS antagonists)2.0
D10Medication Adherence for Cholesterol (Statins)2.0
D11MTM Program Completion Rate for CMR4.0
D12Statin Use in Persons with Diabetes (SUPD)4.0
04 · Crosswalk

Cross-contract transitions

fact_crosswalk · CY 2026

Incoming

No incoming transitions for this contract.

Outgoing